Although other structural and hormonal changes—such as ovarian cysts, uterine fibroids, breast cysts, and altered AMH and TSH levels—did not reach statistical significance, they showed consistent upward trends in the post-COVID-19 group. This evidence concerns the gene AMH and breast cyst.